CDKN2A and cancer: Some of these markers have been identified for their potential functions in cancer: FDX1 can be activated by SF1 and cJUN in Leydig cells [40], CDKN2a usually functions as a tumor suppressor in many cancers [41,42], and DLAT has also been reported to be an oncogene in gastric cancer [43].